Current Report Filing (8-k)
December 08 2022 - 4:43PM
Edgar (US Regulatory)
0000727346
false
0000727346
2022-12-07
2022-12-07
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): December 7, 2022
SELECTIS
HEALTH, INC.
(Exact
Name of Registrant as Specified in its Charter)
Utah |
|
0-15415
|
|
87-0340206
|
(State
or other jurisdiction
of
incorporation) |
|
Commission
File Number |
|
(I.R.S.
Employer
Identification number) |
8480
E. Orchard Road, Ste. 4900, Greenwood Village, CO 80111
(Address
of principal executive offices) (Zip Code)
Registrant’s
telephone number, including area code: (720) 680-0808
(Former
name or former address, if changed since last report)
☐
|
Written
communications pursuant to Rule 425 under the Securities Act |
☐ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act |
☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act |
☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act |
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each Class |
|
Trading
Symbol |
|
Name
of each exchange on which registered |
N/A |
|
N/A |
|
N/A |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☒
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
ITEM
5.07 | SUBMISSION
OF MATTERS TO A VOTE OF SECURITY HOLDERS |
On
December 7, 2022, Selectis Health, Inc., a Utah corporation (the “Company”) convened its Annual Meeting of Stockholders.
As of the record date of the meeting, October 11, 2022, there were 3,067,059 shares of common stock issued and outstanding and eligible
to vote at the meeting. At the meeting, an aggregate of 1,520,998 shares were present, either in person or by proxy, which constituted
a quorum for the meeting.
Below
are the results of the matters voted on by Stockholders at the Annual Meeting as certified by the Final Report of the Inspector of Election.
| 1) | At
the Meeting, the vote to elect one (1) Class I Director to serve for a term of three years
and until the election and qualification of his successor in office, was as follows: |
| |
FOR | | |
WITHHELD | | |
BROKER NON-VOTE | |
Andy Sink | |
1,270,541 | | |
41,080 | | |
209,377 | |
| 2) | At
the Meeting, the vote to ratify the selection of Marcum LLP as the Company’s independent
registered public accounting firm for the current fiscal year ending December 31, 2022, was
as follows: |
FOR | | |
AGAINST | | |
ABSTAIN | |
1,514,159 | | |
6,725 | | |
114 | |
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.
|
|
Selectis Health, Inc.
(Registrant)
|
|
|
|
|
Dated:
December 7, 2022 |
/s/
Lance Baller |
|
|
Lance
Baller, CEO |
Selectis Health (PK) (USOTC:GBCS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Selectis Health (PK) (USOTC:GBCS)
Historical Stock Chart
From Jul 2023 to Jul 2024